Compound ID | 481
WCK-771A
Class: Fluoroquinolone
| Spectrum of activity: | Gram-negative |
| Details of activity: | DNA gyrase inhibitor; Cell membrane inhibitor; effective against MRSA |
| Description: | Arginine salt of the tricyclic fluoroquinolone S-(−)-nadifloxacin |
| Institute where first reported: | Wockhardt, India |
| Year first mentioned: | 2001 |
| Highest developmental phase: | Phase 2 |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/349981768 |
| Guide to Pharmacology: | levonadifloxacin |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.